Your browser doesn't support javascript.
loading
Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivatives.
Krueger, A Chris; Madigan, Darold L; Beno, David W; Betebenner, David A; Carrick, Robert; Green, Brian E; He, Wenping; Liu, Dachun; Maring, Clarence J; McDaniel, Keith F; Mo, Hongmei; Molla, Akhteruzzaman; Motter, Christopher E; Pilot-Matias, Tami J; Tufano, Michael D; Kempf, Dale J.
Afiliação
  • Krueger AC; Abbott Labs, Global Pharmaceutical Research and Development, Abbott Park, IL 60064, USA. a.chris.krueger@abbott.com
Bioorg Med Chem Lett ; 22(6): 2212-5, 2012 Mar 15.
Article em En | MEDLINE | ID: mdl-22342631
The synthesis of several pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine analogs is described with one such analog possessing subnanomolar potency in both genotype 1a and 1b cell culture HCV replicon assays.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Pirimidinas / RNA Viral / Hepacivirus Limite: Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Pirimidinas / RNA Viral / Hepacivirus Limite: Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article